The National Institutes of Health, more commonly referred to as
NIH, is a federal government agency operating under the purview of the
United States Department of Health and Human Services that is primarily
responsible for supporting the nation's biomedical and health-related
research studies.
The grants and programs of the NIH are all magnanimously engineered to assist in the realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).
The primary purpose of the program is to support research initiatives involving physicians who are participating in the care of minorities and who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials.
In addition, the program also serves as an opportunity for practicing oncologists who serve large racial/ethnic minority populations to participate in clinical trials sponsored by the National Cancer Institute.
Essentially, this program is designed to cater to minority populations and to bring forth state-of-the-art cancer clinical trials to minority individuals in their own communities.
The MBCCOP Groups will work by providing patients with access to clinical trials in cancer centers, major university centers, and community programs. And in this manner, this access will be realized through another, separately funded, arm of the program called "Research Bases," which are comprised of participating NCI Cooperative Groups and Cancer Centers.
As a result, the linkages that will soon be developed as a result of this access is expected to facilitate the transfer of advances in cancer prevention/control/treatment practices to minority communities and their physicians.
The National Institutes of Health is ready to administer funds in the amount of $5,500,000 to support the Minority-Based Community Clinical Oncology Program Groups.
The institutions and organizations who will be deemed eligible to submit an application under this program are the following:
a) Public and State Controlled Institutions of Higher Education
b) Native American Tribal Governments
c) Federally recognized Native American Tribal Organizations
d) Nonprofit Organizations
e) Private Institutions of Higher Education
f) For-profit organizations
g) Small businesses
The United States Department of Health and Human Services, the mother agency funding the program, is the nation's premiere agency for protecting the health of all Americans and providing essential human services to everyone, especially to those who are medically challenged and financially vulnerable.
The grants and programs of the NIH are all magnanimously engineered to assist in the realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).
The primary purpose of the program is to support research initiatives involving physicians who are participating in the care of minorities and who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials.
In addition, the program also serves as an opportunity for practicing oncologists who serve large racial/ethnic minority populations to participate in clinical trials sponsored by the National Cancer Institute.
Essentially, this program is designed to cater to minority populations and to bring forth state-of-the-art cancer clinical trials to minority individuals in their own communities.
The MBCCOP Groups will work by providing patients with access to clinical trials in cancer centers, major university centers, and community programs. And in this manner, this access will be realized through another, separately funded, arm of the program called "Research Bases," which are comprised of participating NCI Cooperative Groups and Cancer Centers.
As a result, the linkages that will soon be developed as a result of this access is expected to facilitate the transfer of advances in cancer prevention/control/treatment practices to minority communities and their physicians.
The National Institutes of Health is ready to administer funds in the amount of $5,500,000 to support the Minority-Based Community Clinical Oncology Program Groups.
The institutions and organizations who will be deemed eligible to submit an application under this program are the following:
a) Public and State Controlled Institutions of Higher Education
b) Native American Tribal Governments
c) Federally recognized Native American Tribal Organizations
d) Nonprofit Organizations
e) Private Institutions of Higher Education
f) For-profit organizations
g) Small businesses
The United States Department of Health and Human Services, the mother agency funding the program, is the nation's premiere agency for protecting the health of all Americans and providing essential human services to everyone, especially to those who are medically challenged and financially vulnerable.
No comments:
Post a Comment